Dermata Therapeutics, Inc. — Form D

Dermata Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-07. The offering totals $4.1M, of which $4.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Brittany J. BradrickDirectorSAN DIEGO, CA
Mary J. FisherDirectorSAN DIEGO, CA
David J. HaleDirectorSAN DIEGO, CA
Steven J. MentoDirectorSAN DIEGO, CA
Andrew J. SandlerDirectorSAN DIEGO, CA
Kathleen J. ScottDirectorSAN DIEGO, CA
Wendell J. WierengaDirectorSAN DIEGO, CA
Maria J. Bedoya Toro MuneraExecutive OfficerSAN DIEGO, CA
Christopher J. NardoExecutive OfficerSAN DIEGO, CA
Kyri K. Van HooseExecutive OfficerSAN DIEGO, CA
Gerald ProehlDirectorSAN DIEGO, CA
Gerald ProehlExecutive OfficerSAN DIEGO, CA
Brittany J BradrickDirectorSan Diego, CA
Christopher J NardoExecutive OfficerSan Diego, CA
Maria J Bedoya Toro MuneraExecutive OfficerSan Diego, CA
Steven J MentoDirectorSan Diego, CA
Mary J FisherDirectorSan Diego, CA
Kathleen J ScottDirectorSan Diego, CA
Kyri K Van HooseExecutive OfficerSan Diego, CA
Wendell J WierengaDirectorSan Diego, CA
Andrew J SandlerDirectorSan Diego, CA
David J HaleDirectorSan Diego, CA
Gerald T ProehlDirectorLa Jolla, CA
Gerald T ProehlExecutive OfficerLa Jolla, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2025-02-04D/A$2.5M$2.5M
2025-01-28D$2.5M$2.5M
2024-09-27D$3.5M$3.5M
2023-06-12D

More